Back to Journals » Neuropsychiatric Disease and Treatment » Volume 13

The role of microglia in multiple sclerosis

Authors Luo C, Jian C, Liao Y, Huang Q, Wu Y, Liu X, Zou D, Wu Y

Received 28 April 2017

Accepted for publication 22 May 2017

Published 26 June 2017 Volume 2017:13 Pages 1661—1667


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Professor Wai Kwong Tang

Chun Luo,1 Chongdong Jian,1 Yuhan Liao,1 Qi Huang,1 Yuejuan Wu,1 Xixia Liu,1 Donghua Zou,2 Yuan Wu1

1Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, 2Department of Neurology, The Fifth Affiliated Hospital of Guangxi Medical University and The First People’s Hospital of Nanning, Nanning, People’s Republic of China

Abstract: Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). Microglia are the resident innate immune cells in the CNS; they play an important role in the processes of demyelination and remyelination in MS. Microglia can function as antigen-presenting cells and phagocytes. In the past, microglia were considered to be the same cell type as macrophages, and researchers have different opinions about the role of microglia in MS. This review focuses on the original classification of microglia and their role in the pathogenesis of MS. Moreover, we present a hypothetical model for the role of microglia in the pathogenesis of MS based on recent findings.

Keywords: microglia, multiple sclerosis, macrophage, myelin

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]